Moderna’s mRESVIA FDA approval paves way for mRNA vaccines across multiple indications: GlobalData GlobalData Jun 6, 2024 The drug will be the third prophylactic RSV vaccine to enter the US market following the launches of GSK’s Arexvy and Pfizer’s…
